Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mersana Therapeutics ( (MRSN) ) has issued an announcement.
On February 5, 2025, Mersana Therapeutics updated its corporate presentation on its website for investors to access. The information shared is not considered filed under the Securities Exchange Act of 1934 and is not subject to associated liabilities, nor is it incorporated by reference in any SEC filings unless specifically stated.
More about Mersana Therapeutics
YTD Price Performance: -56.79%
Average Trading Volume: 4,459,674
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $69.85M
See more insights into MRSN stock on TipRanks’ Stock Analysis page.